8-phenyltheophylline has been researched along with Disease Models, Animal in 10 studies
8-phenyltheophylline: purinergic P1 receptor antagonist
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To identify vascular beds where endogenous adenosine plays a significant role as a mediator of resting perfusion alterations associated with sepsis, we tested the hypothesis that adenosine receptor blockade would cause differential regional increases in vascular resistance during intraperitoneal (ip) sepsis in the rat." | 7.70 | Adenosine receptor antagonism affects regional resting vascular resistance during rat peritoneal sepsis. ( Alden, KJ; Ferguson, JL; Law, WR; Motew, SJ; Mourelatos, MG; Sam, AD; Sharma, AC, 1998) |
| "To identify vascular beds where endogenous adenosine plays a significant role as a mediator of resting perfusion alterations associated with sepsis, we tested the hypothesis that adenosine receptor blockade would cause differential regional increases in vascular resistance during intraperitoneal (ip) sepsis in the rat." | 3.70 | Adenosine receptor antagonism affects regional resting vascular resistance during rat peritoneal sepsis. ( Alden, KJ; Ferguson, JL; Law, WR; Motew, SJ; Mourelatos, MG; Sam, AD; Sharma, AC, 1998) |
| "The aims were to examine the role of adenosine receptors in the mechanism of preconditioning in a chronic rabbit model of myocardial infarction; to assess whether the preconditioning effect is blocked by an adenosine receptor antagonist, 8-phenyltheophylline; and to determine whether an adenosine A1 receptor agonist, R(-)N6-2-phenylisopropyl adenosine (R-PIA), mimics infarct size limitation by preconditioning." | 3.68 | Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. ( Iimura, O; Miki, T; Miura, T; Shimamoto, K; Tsuchida, A, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Coelho, JE | 1 |
| Rebola, N | 1 |
| Fragata, I | 1 |
| Ribeiro, JA | 1 |
| de Mendonça, A | 1 |
| Cunha, RA | 1 |
| Ming, Z | 1 |
| Fan, YJ | 1 |
| Yang, X | 1 |
| Lautt, WW | 1 |
| Traverse, JH | 1 |
| Chen, Y | 1 |
| Hou, M | 1 |
| Li, Y | 1 |
| Bache, RJ | 1 |
| Nayebpour, M | 1 |
| Billette, J | 1 |
| Amellal, F | 1 |
| Nattel, S | 1 |
| Urabe, K | 1 |
| Miura, T | 2 |
| Iwamoto, T | 1 |
| Ogawa, T | 1 |
| Goto, M | 1 |
| Sakamoto, J | 1 |
| Iimura, O | 2 |
| Motew, SJ | 1 |
| Sam, AD | 1 |
| Mourelatos, MG | 1 |
| Sharma, AC | 1 |
| Alden, KJ | 1 |
| Ferguson, JL | 1 |
| Law, WR | 1 |
| Tsuchida, A | 1 |
| Miki, T | 1 |
| Shimamoto, K | 1 |
| Richardt, G | 1 |
| Waas, W | 1 |
| Kranzhöfer, R | 1 |
| Mayer, E | 1 |
| Schömig, A | 1 |
10 other studies available for 8-phenyltheophylline and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Hypoxia-induced desensitization and internalization of adenosine A1 receptors in the rat hippocampus.
Topics: 2-Chloroadenosine; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Disease Models, Animal; En | 2006 |
Contribution of hepatic adenosine A1 receptors to renal dysfunction associated with acute liver injury in rats.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Chemical and Drug Ind | 2006 |
Effect of K+ATP channel and adenosine receptor blockade during rest and exercise in congestive heart failure.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Blood Flow Velocity; Cardiac Pacing, Artifi | 2007 |
Effects of adenosine on rate-dependent atrioventricular nodal function. Potential roles in tachycardia termination and physiological regulation.
Topics: Adenosine; Animals; Atrioventricular Node; Cardiac Pacing, Artificial; Disease Models, Animal; Elect | 1993 |
Preconditioning enhances myocardial resistance to postischaemic myocardial stunning via adenosine receptor activation.
Topics: Animals; Disease Models, Animal; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reper | 1993 |
Adenosine receptor antagonism affects regional resting vascular resistance during rat peritoneal sepsis.
Topics: Adenosine; Animals; Cardiac Output; Disease Models, Animal; Hemodynamics; Male; Organ Specificity; P | 1998 |
Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning.
Topics: Animals; Disease Models, Animal; Hemodynamics; Male; Myocardial Infarction; Myocardium; Phenylisopro | 1992 |
Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia.
Topics: Adenosine; Animals; Chromatography, High Pressure Liquid; Coronary Circulation; Coronary Disease; Di | 1987 |